Option Care Health Q2 2024: revenue +14.8% to $1.23B; net income down 53.6% to $53M

Option Care Health, Inc.

2024-Q2 EPS reported $0.56 revenue$2,373,238,000

Net revenue of $1,227.2M, up 14.8% YoY; net income of $53.0M ($0.30 EPS) vs $114.4M ($0.63 EPS) in Q2 2023.
Adjusted EBITDA of $108.4M, down 1.5% from $110.1M; gross margin fell to 20.3% from 23.5%.
FY 2024 guidance: revenue $4.75-4.85B, adjusted EBITDA $435-450M, cash from ops at least $300M.
Repurchased ~$78.1M of stock during Q2; amended credit facility to lower interest rate and add $50M liquidity.
Q2 2023 results included a $62.8M termination payment from Amedisys; adjusting, core operations showed margin pressure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.